A Case Series of Patients with Isolated IgG4-related Hypophysitis Treated with Rituximab 
The acute presentation of immunoglobulin G4 (IgG4)-related hypophysitis can be indistinguishable from other forms of acute hypophysitis, and histology remains the diagnostic gold standard.
Latest Published Articles
Abstract Primary adrenal leiomyosarcoma (PAL) is a rare, high-grade proliferating mesenchymal tumor with a considerable risk of metastasis, deriving from the smooth muscle wall of a central adrenal vein, or its tributaries. Roughly 40 patients with PAL have been reported in the literature. Herein, we present 3 patients ...
Abstract The natriuretic peptide (NP) system is composed of 3 distinct peptides (atrial natriuretic peptide or ANP, B-type natriuretic peptide or BNP, and C-type natriuretic peptide or CNP) and 3 receptors (natriuretic peptide receptor-A or NPR-A or particulate guanynyl cyclase-A natriuretic peptide receptor-B or NPR-B or ...
Abstract Familial chylomicronemia syndrome (FCS) is a rare disorder associated with chylomicronemia (CM) and an increased risk of pancreatitis. Most individuals with CM do not have FCS but exhibit multifactorial CM (MCM), which differs from FCS in terms of risk and disease management. This study aimed to investigate ...
Abstract Context Concordance for persistent islet autoimmunity (IA) and type 1 diabetes in monozygotic twins after probands are diagnosed is variable (30%-70%). Risk for development of IA in dizygotic twins is thought to be similar to nontwin siblings. Little is known in regard to the development of celiac autoimmunity ...
NYT Opinion Editorial by JES EiC
Read “7 Medical Leaders to Politicians: Save Lives, Not Wall Street” by J. Larry Jameson, MD, PhD in The New York Times.
JES now featured in ESCI
Journal of the Endocrine Society (JES) is included in the Emerging Sources Citation Index (ESCI), part of the Core Collection of the Clarivate Web of Science. JES’s inclusion enhances its visibility and discoverability.
JES articles in PMC
Journal of the Endocrine Society (JES) is now available as full text from PubMed Central, the Library's archive of open access articles. All JES articles are deposited immediately upon publication in their final form. Subsequently they will also be listed in PubMed and receive PMIDs.
Why publish in JES?
J. Larry Jameson, MD, PhD, Editor-in-Chief, discusses the benefits of publishing open access in Journal of the Endocrine Society (JES). JES invites submissions in all areas of basic, translational, and clinical endocrinology. Article types include original research, methods & tools, databases, and images. Submit your paper or preprint today.
ORCiD
All submitting authors are required to provide an ORCiD (Open Researcher and Contributor ID) when uploading a manuscript. An author identification registry, ORCiD allows you to be uniquely identified with your work by eliminating name ambiguity. Register for free today!
Sign up for Alerts
Register to receive email alerts as soon as new Journal of the Endocrine Society articles are published online.
Committee on Publication Ethics
JES is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Format-Neutral Submission:
Submit new manuscripts as a single Word, RTF, or PDF file. Formatting not required until revision.
Benefits of Open Access
Read about OUP's expertise in both gold and green Open Access models. Journal of the Endocrine Society is listed in the Directory of Open Access Journals, a curated online directory of high quality, open access, peer-reviewed journals.
